Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of July 2016, with the report signed on July 7, 2016. The document serves as a report of foreign private issuer transactions pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The content is strictly limited to a consolidated report of securities and derivatives transactions by the company's Board of Directors, Management, and Fiscal Council in compliance with Article 11 of CVM Instruction # 358/2002.
Key Financial Metrics
The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document contains only transactional data regarding insider trading activities.
| Group | Transaction Type | Quantity | Total Volume (R$) |
|---|---|---|---|
| Management | Net Sell | 8,500 | 160,425.00 |
| Board of Directors | No Activity | 0 | 0.00 |
| Fiscal Council | No Activity | 0 | 0.00 |
Material Changes
There are no material changes to the company's financial position or operations reported in this filing. The only changes recorded are in the shareholdings of specific insiders:
- Management: Net reduction of 8,500 common shares. This includes a donation of 3,100 shares and sales of 11,600 shares through the intermediary "Ágora Corretora" at prices ranging from R$ 18.23 to R$ 19.35.
- Board of Directors: No change in holdings; initial and final balances remained at 28,913,125 common shares and 556,329 ADRs.
- Fiscal Council: No change in holdings; balance remained at 7,225 common shares.
Guidance, Outlook, and Risks
The filing text does not provide any management commentary, forward-looking guidance, outlook, risk factors, contingencies, or discussion of unusual items. The document is a statutory disclosure of insider trading activity only.
Investor Verification Checklist
- Verify the specific identities of the management personnel who executed the 11,600 share sales to assess potential insider sentiment.
- Confirm the final shareholding percentages for the Board of Directors (0.1840% common, 0.0035% ADR) and Management (0.0465% common, 0.0081% ADR) against the company's total outstanding shares.
- Review the company's Form 20-F or quarterly earnings releases for actual financial performance metrics, as this Form 6-K contains none.
- Note that the transaction dates listed in the table (e.g., June 30) appear to reference the prior month's activity despite the filing header stating "For the month of July, 2016"; verify the exact reporting window in the original Portuguese filing if precise timing is critical.